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Patients who have suffered burns frequently experience psychological consequences, among which anxiety
disorders are prominent. Benzodiazepines are commonly administered to treat these symptoms. The effects of
benzodiazepines on healing may not be direct but rather are modulated by alterations of the sleep architecture.
This hypothesis is supported by studies that demonstrate the effects of benzodiazepines on the immune system and
the inflammatory profile under both normal sleep conditions and during sleep deprivation, particularly rapid eye
movement sleep deprivation.
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INTRODUCTION
Damage to the skin triggers mechanisms of repair that are
collectively called healing. This process commences imme-
diately after injury and is composed of the following three
main phases: inflammatory, proliferative, and maturation.
The wound-healing process is not linear, and these phases
depend on various intrinsic and extrinsic factors. Several
factors may influence the healing process, including age,
nutritional status, diabetes, atherosclerosis, stress, lack of
sleep, and the integrity of the immune system (1-3). The
integrity of the immune system is indispensable during the
healing process, particularly during the recovery of tissue
after burns, when defense cells and inflammatory mediators
act in unison to promote tissue regeneration, cytokine
production, and bacterial clearance.
Among patients who have suffered burns, a common
sequela is the psychological consequences, among which
anxiety disorders are the most prevalent (4). A therapeutic
option for anxiety is the prescription of benzodiazepines
(BDZ) to deal with the ensuing stress caused by the injury.
The choice of this drug for burn patients has grown
considerably in the past years and 77% of burn patients
received this drug in 2001 (5,6).
Recently, some studies examined the effects of midazolam,
a commonly used BZD, upon the burn wound. Babcock et al.
treated mice with midazolam (1 mg/kg) daily after a burn
injury and observed a decrease in IL-1b, TNF-a, IL-6, IL-10,
and TGF-b levels compared to saline-treated mice (7).
Moreover, the chemokines (MIP-1a, MIP-1b, and MIP-2) in
the wound were increased significantly by midazolam.
Another study by this group, using the same treatment with
midazolam, investigated whether psychological stress (e.g.,
predator exposure) could alter survival following Pseudomo-
nas aeruginosa infection. The results showed that midazolam
had a protective effect in mice (8). Together, these studies
suggest that BDZ canmodulate the immune system and a host
of inflammatory mediators, leading to a detrimental effect on
healing and tissue regeneration.
Based on this evidence, we hypothesize that inflammation
of wounded tissue may not be a direct effect of midazolam
but rather a consequence of sleep alterations caused by the
administration of BZD.
STRESS, ANXIETY, AND THE IMMUNE SYSTEM
An important factor during the treatment of wounded
patients is the stress resulting from the injury, which may
affect the immune system. Another consideration is the
interaction between stress and the immune system. As
demonstrated by McGhee et al. (9), lesions caused by burns
or other wounds are potentially stressful events and are one
reason why the use of BZD among such patients has seen a
rise. However, stress, anxiety, and the immune system are
intimately associated, especially when dealing with inflam-
mation and healing. Specifically, dermatologic lesions can
trigger psychological alterations such as stress (10), and
stressful situations may trigger alterations in the immune
system as a consequence of the activation of the hypotha-
lamic-pituitary adrenal axis (HPA) and increased glucocorti-
coids (11; see (16) for review), whichmay then impact healing.
Increased psychological stress is associated with a higher
incidence of skin dermatoses (such as psoriasis and derma-
titis) (12-14). This abnormality in the skin may interfere in the
healing process and compromise the skin’s ability to act as an
immune barrier, which is one of its main functions (15).
Padgett et al. (17) observed retardation in the healing process
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in an animal model submitted to immobilization stress. In
addition, immobilized mice presented increased corticoster-
one when compared to controls. Thus, delayed healing was
correlated with higher concentrations of corticosterone,
suggesting that a perturbation of neuroendocrine home-
ostasis may modulate the repair process of the lesion. Taken
as a whole, these results suggest that alterations in the
immune function are associated with stress and may exert
further complications that hamper the regeneration and
integrity of the skin.
EFFECTS OF SLEEP RESTRICTION ON THE IMMUNE
SYSTEM
Recently, Kronholm and collaborators (18) showed that
average sleep time has fallen approximately two hours per
night over the past 50 years. This reduction in sleep time,
which is characteristic of a modern lifestyle, may lead to
repercussions upon one’s health and well-being. In parti-
cular, several studies have shown that sleep deprivation
(SD) causes marked and adverse alterations in the immune
system (19-24). One study demonstrated that forced
wakefulness in the first half of the night (from 22:00 to
3:00) and in the second half of the night (from 3:00 to 7:00)
promoted a reduction in the activity of natural killer (NK)
cells (25). These results suggest that a few hours of sleep
deprivation is sufficient to cause adverse effects on the
integrity of the immune system. Recently, Ruiz et al. (24)
reported that a total of two nights of SD resulted in
increased leukocytes and neutrophils in healthy men
compared to their baseline values. After 24 hours of sleep
recovery, those figures returned to the values observed at
baseline. However, the concentrations of monocytes, eosi-
nophils, basophiles, and cytokines (IL-1b, IL-2, IL-4, IL-6, IL-
10, TNF-a, and IFN-c) remained unaltered after the SD
protocol. Thus, SD may alter the immune profile. BZD also
influence the immune system, affecting cytokines, neutro-
phils, and macrophages (26-28).
RELATIONSHIPS BETWEEN THE USE OF BZD AND
SLEEP
When first administered, hypnotics and anxiolytics of the
BZD class improve sleep efficiency by reducing the latency
of sleep onset and arousals during the night (29). However,
after chronic use, BZDs inhibit the desynchronization
process, reducing REM sleep due to a decrease of the
neurotransmitter GABA (30). Additionally, BZDs increase
slow-wave sleep and, in the long term, lead to a condition of
REM-sleep restriction (31).
The relationship between sleep deprivation, immune
parameters, and skin integrity remains under investigation.
Mostaghimi et al. (32) showed that rats subjected to five
days of sleep deprivation by the multiple-platform method
did not present a slower healing process when compared
to controls. Similarly, Landis and Whitney (33) did not
observe any detrimental effects on healing at the cellular
level in rats that were sleep-deprived for 72 h using the
single-platform method. Although these data cannot be
interpreted as that the lack of sleep jeopardizes the healing
process, nevertheless it is possible that those effects are
mediated by other molecular mechanisms that are cur-
rently unidentified.
The wound healing process consists in a perfectly
coordinated cascade of cellular and molecular events that
interact to produce the reconstitution of the tissue. There are
several studies in the literature showing the adverse effects,
particularly stress, in wound healing in animal models and
humans. It is known that sleep deprivation is an event
inherent to stress and we can hypothesize that the stress
caused by sleep deprivation results in negative conse-
quences in the healing process. However, it is a challenge
for researchers to investigate the effects of sleep deprivation
on the healing process due to the complexity of this process.
INTEGRATION OF CONCEPTS
Recovery from skin lesions, such as burns, is intimately
associated with specific inflammatory mediators, which
entails a direct association with the immune system. An
example of such an association can be found in the
formation of granulation tissue as macrophages release a
variety of pro-inflammatory cytokines (interleukin 1 and 6)
and growth factors (fibroblast growth factor [FGF], epider-
mal growth factor EGF, transforming growth factor-beta
[TGF-b], and platelet-derived growth factor [PDGF]). The
formation of granulation tissue is an essential process for
the synthesis, deposition, and organization of new extra-
cellular matrix [see review, (34)]. Thus, the efficacy of the
healing process is directly dependent upon the integrity of
the immune system. However, particularly when the
wound is of great extent, depth, or severity, symptoms
such as anxiety and stress can be observed, making the
relationship between stress and the immune system
bidirectional; the patient is stressed by the wound, and
stress can compromise the immune system, slowing healing
time. Thus, stress itself is responsible for the retardation of
healing time (35).
Given the detrimental effects of stress in these situations,
BZDs are commonly administered as a means of attenuating
anxiety and stress symptoms (36). However, chronic
consumption of BZD also provokes significant immunolo-
gical disorders in humans (37) and alterations in sleep that
may also affect immune function.
Therefore, we propose that the effects of BZD on healing
are not direct, but rather are modulated by alterations of
sleep, which then affect the immune system (Figure 1). This
hypothesis is supported by studies that demonstrate the
effects of BZD on the characteristics of the immune system
and the inflammatory profile in normal sleep and sleep
deprivation, particularly in REM sleep deprivation.
PRACTICAL IMPLICATIONS
The potential damage caused by BZD to the healing
process in patients who have skin wounds contradicts the
use of these compounds in such cases (6). BZDs are used in
such cases to improve the mental state of the patient and, as
a consequence, promote better tissue regeneration; however,
that advantage is offset by these potentially detrimental
effects.
There are two important considerations that follow from
our hypothesis. The first is that the hypothesis presents a
novel manner of approaching the clinical condition in a
patient with skin lesions. In this scenario, sleep becomes an
important factor for that patient’s improvement. The second
is that this investigation opens a debate on the use of BZD
for patients with skin lesions. BZDs are not the only drugs
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available as a therapeutic option for patients with anxiety.
Medications such as buspirone, tricyclic antidepressants,
and beta-blockers may be employed. Additionally, the
effects of these medications on sleep differ from the effects
of BZD; thus, they may reduce the negative effects on
healing. This difference is particularly important when
considering sleep deprivation and especially REM sleep
deprivation. In these cases, the use of non-BZD hypnotics
may be an option.
The physiological integrity of the skin is essential for the
health of living creatures. Sleep is also a biological process
that is fundamental for the quality of an individual’s mental,
emotional and physical life. Thus, our hypothesis combines
the interaction of BZD with sleep and the possible influence
on the healing process. However, additional studies,
conducted in animals and humans, are necessary to test
this hypothesis. This hypothesis opens opportunities for
new discussions regarding this theme.
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